DFB Pharmaceuticals, a Fort Worth, Texas-based private investment group with an entrepreneurial drive for developing new products and businesses in healthcare, announced the promotion of Colin Marr to President of Phyton Ltd.
Phyton Biotech Wins Grant to Develop New Approaches [...]
Phyton Biotech showcased plant cell fermentation at CPhI [...]
Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the [...]
Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO)
Patent Application for GenSpera Partner Phyton Biotech Is Published [...]
GenSpera Announces Partnership With Global SupplierCompany to Partner with [...]